Medical University Study Supports Nozin Nasal Sanitizer

August 5, 2014

MUSC The Medical University of South Carolina (MUSC) reports that a recent study on the use of Nozin Nasal Sanitizer antiseptic is a positive development in the fight to lower health care-associated infections. In an article on the study using Nozin Nasal Sanitizer published on the MUSC web site Shaun Nguyen, M.D., a principal investigator for the study, said, “We were open-minded and wanted to come up with a hypothesis to determine whether or not a low-cost intervention could reduce staph carriage.  It was neat that it worked." The article noted that in addition to the relatively low cost of Nozin Nasal Sanitizer, that fact that it is not an antibiotic is also key given the serious concerns about overuse of antibiotics and build up resistance. The principal investigators Dr. Shaun Nguyen and Dr. Lisa Steed see utility of the Nozin product in hospitals and long term care facilities to help control infections. An article on the MUSC study using Nozin has been published in the August 2014 issue of the American Journal of Infection Control. A record of the Nozin study is also available at clinicaltrials.gov.


Health Professionals:
Request a comprehensive analysis of your MRSA & MSSA colonization risk mitigation protocols today.

© 2004-2021 Global Life Technologies Corp. All rights reserved. Nozin® Nasal Sanitizer® antiseptic is an OTC topical antiseptic drug and no claim is made that it has an effect on any specific disease. | Patent Nos.